Insider Trading Update: Medical Transcription Billing, Corp. $MTBC

ce26ba1d60de0c5f6d6ed136bdddb4e7

Medical Transcription Billing, Corp. (MTBC) insider have most recently took part in a trading activity. On Dec 1, 2017 Haq Mahmud Ul, CEO, 10% Owner bought 30,000 shares having total worth of $87,900 at the price of $2.93 per share, following the transaction a total of 5,017,070 shares owned by Haq Mahmud Ul.

The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 sell activities .Furthermore, over the past 12 months , the stock was traded 1 times by insiders. In 1 of these trades, the insider was a seller .

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 0 1 137.7%
12 Month 0 1 229.55%

Shares of Medical Transcription Billing, Corp. (MTBC) traded up 0.35% on Dec 1, 2017, hitting $2.9. 350,737 shares of the company’s stock traded hands. Medical Transcription Billing, Corp. has a 52 week low of $0.39 and a 52 week high of $4.09. The company’s market cap is $9 million.

Medical Transcription Billing, Corp. (MTBC) last announced its earnings results on Nov 6, 2017. The company reported -0.03 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.13 by $0.1. The company had revenue of $8 million for the quarter, compared to the consensus estimate of $8 million. During the same quarter in the previous year, the company posted -0.02 earnings per share. The company’s revenue for the quarter was up 41% on a year-over-year basis.

2017-11-06 2017-08-03 2017-05-10 2017-03-31 2016-11-10 2016-08-11 2016-05-11 2016-03-24 2015-11-12 2015-08-12
earnings per share -0.03 -0.01 -0.08 -0.12 -0.02 -0.03 -0.02 0.01 -0.04 -0.02
Revenue(M) 7.51 7.79 8.22 8.83 5.34 5.21 5.11 5.36 5.61 5.97

Medical Transcription Billing, Corp. has been the subject of a number of recent research reports. Analysts at Chardan Capital Maintains shares of Medical Transcription Billing, Corp. to an Buy rating in a research note. They now have a $2.75 price target on the stock.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.